The trajectory of Viagra presents a complex picture for shareholders. While the initial launch generated significant gains, the expiration of its patent opened the avenue to cheaper versions, dramatically eroding https://bookmarktiger.com/story21584419/sildenafil-and-big-pharma-a-volatile-opportunity